Results 11 to 20 of about 589 (114)

International insights into bullying in patients with atopic dermatitis: Global trends and key predictors. [PDF]

J Eur Acad Dermatol Venereol
Journal of the European Academy of Dermatology and Venereology, Volume 40, Issue 5, Page e379-e381, May 2026.
Dodiuk-Gad R, Takaoka R, Misery L, Tan J, Gu C, Luger T, Aslanian FP, Prakoeswa CRS, Demessant Flavigny A, Le Floc'hc C, Kerrouche N, Merhand S, Smith Begolka W, de Tena Smith ÁL, Burstein S, Kerob D, Taieb C, Skayem C, Halioua B, Tempark T, Kelbore AG, Seneschal J, Stratigos A, Steinhoff M, Silverberg JI.   +24 more
europepmc   +2 more sources

Suicidal ideation in patients with atopic dermatitis: A case-control study on 23,191 adults. [PDF]

J Eur Acad Dermatol Venereol
Journal of the European Academy of Dermatology and Venereology, Volume 40, Issue 5, Page e375-e378, May 2026.
Seneschal J, Halioua B, Tan J, Gu C, Luger T, Dodiuk-Gad R, Takaoka R, Aslanian FP, Prakoeswa CRS, Demessant-Flavigny AL, Le Floc'h C, Kerrouche N, Merhand S, Begolka WS, de Tena Smith ÁL, Burstein S, Kerob D, Taieb C, Skayem C, Kelbore AG, Misery L, Tempark T, Stratigos A, Steinhoff M, Silverberg JI.   +24 more
europepmc   +2 more sources

Assessing D-Squame as a Minimally Invasive Technique to Evaluate the Cutaneous Immune Response mRNA in a Dog Model of Canine Atopic Dermatitis. [PDF]

Vet Dermatol
ABSTRACT Background Canine atopic dermatitis (cAD) is a multifactorial, inherited skin disease, estimated to affect ≤ 15% of dogs. Studies of skin messenger mRNA in cAD currently use invasive methods, including blood sampling and biopsy collection, whilst advances in human atopic dermatitis study methodology have demonstrated reliable use of minimally ...
Langon X, Mosca M, Milhau N, Legain M, Idée A, Pin D.   +5 more
europepmc   +2 more sources

A Novel Topical Emollient Plus for Canine Atopic Dermatitis: A Clinical Trial Assessing Efficacy and User Acceptance. [PDF]

Vet Dermatol
Background: Canine atopic dermatitis (cAD) is a common, chronic skin condition characterised by epidermal barrier dysfunction, immune dysregulation and cutaneous dysbiosis. While “emollient plus” formulations are widely used in human atopic dermatitis, their role in cAD remains underexplored. Hypothesis/Objectives: To evaluate the clinical efficacy and
Fernandes B, Mendes AC, Alves SP, Schmidt V, Bizarro AF, Pinto M, Pereira H, Marto J, Lourenço AM.   +8 more
europepmc   +2 more sources

Efficacy of Der f 2/Zen 1-LAMP1 Plasmid-Based Vaccine Immunotherapy in Dogs With Atopic Dermatitis: A Proof-of-Concept Study. [PDF]

Vet Dermatol
Background: DNA‐based vaccination rapidly induces strong cellular and humoral immune responses, which may be enhanced by inclusion of lysosomal‐associated membrane protein‐1 (LAMP). Objectives: This proof‐of‐concept study evaluated the efficacy and safety of a Der f 2/Zen 1‐LAMP‐based DNA vaccine immunotherapy in client‐owned dogs with nonseasonal AD ...
Bizikova P, Matsumoto C, Ogino S, Tsukui T, Love K, Murphy M, Herrmann I.   +6 more
europepmc   +2 more sources

Randomised, Double-Blinded, Placebo-Controlled Challenge Test With Single Food Items in Dogs With Atopic Dermatitis and Adverse Food Reactions. [PDF]

Vet Dermatol
ABSTRACT Background Identification of offending foods in dogs with adverse food reactions is usually based on “deterioration” during open food challenges. Objectives To examine the placebo effect during double‐blinded, placebo‐controlled food challenges using a predefined set of criteria for relapse.
Sofou EI, Samuel E, Aleksandrova S, Chatzis M, Saridomichelakis MN.   +4 more
europepmc   +2 more sources

Machine Learning Model for an App-Based Tool to Assist With the Diagnosis of Canine Atopic Dermatitis. [PDF]

Vet Dermatol
Canine atopic dermatitis (cAD) is a chronic condition requiring life‐long management. Accurate diagnosis can be challenging, with no reliable diagnostic test. This study aimed to generate a simple diagnostic model for cAD. This model is a relevant prototype for an app‐based tool to support general practitioners in the diagnosis of cAD alongside ...
Langon X, Montoya M, Gourdon I.
europepmc   +2 more sources

Tolerability and Feasibility of Minimally Invasive Canine Skin Sampling: Excellent Tolerability Meets Transcriptomic Challenges. [PDF]

Vet Dermatol
ABSTRACT Background Advances in transcriptomics have driven the demand for minimally invasive, reproducible and high‐yield skin sampling methods, particularly for studying inflammatory skin diseases in companion animals. Hypothesis/Objectives We tested tolerability, feasibility and RNA quantity and quality of three minimally invasive skin sampling ...
Herrmann I, Mamo LB, Dickey AN.
europepmc   +2 more sources

Evaluation of filaggrin 2 expression in dogs with atopic dermatitis before and after oclacitinib maleate administration. [PDF]

Vet Dermatol
Background – Canine atopic dermatitis (cAD) is a chronic, inflammatory, multifactorial and pruritic disease. The presence of skin barrier impairment (e.g. filaggrin alterations), along with abnormal immune responses, can negatively impact cutaneous barrier function.
Villalobos WR, Ferreira T, Borek F, Santoro D, Ferrer L, Farias M.   +5 more
europepmc   +2 more sources

Effect of Gabapentin Administered With Prednisolone, Ciclosporin or a Placebo on Clinical Outcomes and Motor Activity in Cats With Atopic Skin Syndrome: A Prospective, Blinded, Placebo-Controlled Study. [PDF]

Vet Dermatol
Background: Gabapentin reportedly decreases central sensitisation, a disorder associated with chronic pruritus in humans, although this is not well documented in cats. Its combined use with the standard antipruritic therapy for feline atopic skin syndrome (FASS) is not yet described.
Morency J, Troncy É, Delsart A, Otis C, Del Castillo JRE, Gonzales A, Ross J, Moreau M, Pelletier JP, Martel-Pelletier J, Sauvé F.   +10 more
europepmc   +2 more sources